The amorphous → metastable and metastable → stable crystalline phase transitions of nifedipine and their relationship with polymorph composition during storage at controlled temperature/humidity conditions were investigated. Metastable form C was produced from both differential scanning calorimetry (DSC) thermal treatment and storage [22 °C/0% and 75% relative humidity (RH)] of the amorphous form. Amorphous conversion rate accelerated with storage temperature up to 40 °C, but a further 8 °C increase to 48 °C (3 °C above the glass transition) resulted in a more than 12-fold decrease in amorphous conversion rate. DSC and X-Ray diffraction (XRD) analysis revealed a faster amorphous conversion rate relative to the metastable crystal transformat...
Formulation of new drug candidates is becoming increasingly difficult due to the low solubility asso...
During drug discovery and development the thermodynamics and kinetics of crystal form transitions mu...
Formulation of new drug candidates is becoming increasingly difficult due to the low solubility asso...
Purpose. To examine the thermal transition(s) between different polymorphic forms of Nifedipine and ...
We report the first structural determination of the metastable β polymorph of nifedipine (NIF) by si...
Recrystallization of amorphous drugs is currently limiting the simple approach to improve solubility...
The thermodynamic properties of a new antidepressant drug are studied from room temperature to 200 °...
In this study the polymorphs of tolbutamide, an oral hypoglicemiant used on Diabetes Mellitus type I...
The structure adopted by a given compound when it is crystallized normally exerts a profound effect ...
The formation and physical stability of amorphous sulfathiazole obtained from polymorphic forms I an...
Controlling the shape of crystals is of great practical relevance in pharmaceutical manufacturing. I...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...
Abstract: The polymorphism of nifedipine under controlled relative humidity has been studied by both...
Formulation of new drug candidates is becoming increasingly difficult due to the low solubility asso...
Formulation of new drug candidates is becoming increasingly difficult due to the low solubility asso...
During drug discovery and development the thermodynamics and kinetics of crystal form transitions mu...
Formulation of new drug candidates is becoming increasingly difficult due to the low solubility asso...
Purpose. To examine the thermal transition(s) between different polymorphic forms of Nifedipine and ...
We report the first structural determination of the metastable β polymorph of nifedipine (NIF) by si...
Recrystallization of amorphous drugs is currently limiting the simple approach to improve solubility...
The thermodynamic properties of a new antidepressant drug are studied from room temperature to 200 °...
In this study the polymorphs of tolbutamide, an oral hypoglicemiant used on Diabetes Mellitus type I...
The structure adopted by a given compound when it is crystallized normally exerts a profound effect ...
The formation and physical stability of amorphous sulfathiazole obtained from polymorphic forms I an...
Controlling the shape of crystals is of great practical relevance in pharmaceutical manufacturing. I...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...
Flufenamic acid (FFA) is a highly polymorphic drug molecule with nine crystal structures reported in...
Abstract: The polymorphism of nifedipine under controlled relative humidity has been studied by both...
Formulation of new drug candidates is becoming increasingly difficult due to the low solubility asso...
Formulation of new drug candidates is becoming increasingly difficult due to the low solubility asso...
During drug discovery and development the thermodynamics and kinetics of crystal form transitions mu...
Formulation of new drug candidates is becoming increasingly difficult due to the low solubility asso...